495 related articles for article (PubMed ID: 1314148)
1. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
2. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
Yen TC; King KL; Yang AH; Liu RS; Yeh SH
J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
[TBL] [Abstract][Full Text] [Related]
4. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
5. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
Becker W; Börner W; Reiners C
Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
8. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
10. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
[TBL] [Abstract][Full Text] [Related]
11. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
12. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
Mojiminiyi OA; Udelsman R; Soper ND; Shepstone BJ; Dudley NE
Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
[TBL] [Abstract][Full Text] [Related]
13. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ
Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
[TBL] [Abstract][Full Text] [Related]
14. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
[TBL] [Abstract][Full Text] [Related]
15. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
[TBL] [Abstract][Full Text] [Related]
16. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma.
Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N
Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022
[TBL] [Abstract][Full Text] [Related]
17. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications.
Basu S; Nair N; Awasare S; Tiwari BP; Asopa R; Nair C
Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330
[TBL] [Abstract][Full Text] [Related]
18. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
20. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]